vs
Profound Medical Corp.(PROF)与Sunlands Technology Group(STG)财务数据对比。点击上方公司名可切换其他公司
Sunlands Technology Group的季度营收约是Profound Medical Corp.的1.7倍($10.1M vs $6.0M),Sunlands Technology Group净利率更高(24.0% vs -136.8%,领先160.7%)
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业,专注于为医疗领域开发并提供相关软件产品,面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年,该公司全球员工规模超9200人,业务覆盖56个国家,拥有超过160万用户。
STG Partners是一家总部位于美国加利福尼亚州门洛帕克的私募股权公司,其前身交响科技集团由罗梅什·瓦德瓦尼等创始人于2002年成立,2017年完成重组后更名为STG Partners。截至2025年3月,该机构通过19只集合投资工具为客户管理着约120亿美元资产。
PROF vs STG — 直观对比
营收规模更大
STG
是对方的1.7倍
$6.0M
净利率更高
STG
高出160.7%
-136.8%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $6.0M | $10.1M |
| 净利润 | $-8.2M | $2.4M |
| 毛利率 | 66.8% | 88.5% |
| 营业利润率 | -123.3% | 26.5% |
| 净利率 | -136.8% | 24.0% |
| 营收同比 | — | — |
| 净利润同比 | — | — |
| 每股收益(稀释后) | $0.27 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PROF
STG
| Q4 25 | $6.0M | — | ||
| Q3 25 | $5.1M | $10.1M | ||
| Q2 25 | $2.0M | $9.3M | ||
| Q1 25 | $2.3M | — | ||
| Q4 24 | — | $9.7M | ||
| Q2 24 | — | $10.0M | ||
| Q3 23 | — | $9.9M | ||
| Q2 23 | — | $10.0M |
净利润
PROF
STG
| Q4 25 | $-8.2M | — | ||
| Q3 25 | $-8.0M | $2.4M | ||
| Q2 25 | $-15.7M | $1.4M | ||
| Q1 25 | $-10.7M | — | ||
| Q4 24 | — | $1.8M | ||
| Q2 24 | — | $2.2M | ||
| Q3 23 | — | $2.5M | ||
| Q2 23 | — | $3.3M |
毛利率
PROF
STG
| Q4 25 | 66.8% | — | ||
| Q3 25 | 77.7% | 88.5% | ||
| Q2 25 | 81.7% | 85.2% | ||
| Q1 25 | 79.2% | — | ||
| Q4 24 | — | 83.3% | ||
| Q2 24 | — | 85.2% | ||
| Q3 23 | — | 87.8% | ||
| Q2 23 | — | 88.7% |
营业利润率
PROF
STG
| Q4 25 | -123.3% | — | ||
| Q3 25 | -176.2% | 26.5% | ||
| Q2 25 | -696.9% | 15.2% | ||
| Q1 25 | -477.0% | — | ||
| Q4 24 | — | 13.4% | ||
| Q2 24 | — | — | ||
| Q3 23 | — | 23.3% | ||
| Q2 23 | — | 29.6% |
净利率
PROF
STG
| Q4 25 | -136.8% | — | ||
| Q3 25 | -157.7% | 24.0% | ||
| Q2 25 | -792.3% | 15.4% | ||
| Q1 25 | -458.1% | — | ||
| Q4 24 | — | 18.2% | ||
| Q2 24 | — | 21.5% | ||
| Q3 23 | — | 25.1% | ||
| Q2 23 | — | 33.0% |
每股收益(稀释后)
PROF
STG
| Q4 25 | $0.27 | — | ||
| Q3 25 | $0.26 | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.36 | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | $0.31 | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $59.7M | $15.1M |
| 总债务越低越好 | $4.5M | — |
| 股东权益账面价值 | $66.4M | $17.7M |
| 总资产 | $77.5M | $41.2M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势,按日历期对齐
现金及短期投资
PROF
STG
| Q4 25 | $59.7M | — | ||
| Q3 25 | $24.8M | $15.1M | ||
| Q2 25 | $35.2M | — | ||
| Q1 25 | $46.4M | — | ||
| Q4 24 | — | $15.6M | ||
| Q2 24 | — | $18.7M | ||
| Q3 23 | — | $16.5M | ||
| Q2 23 | — | — |
总债务
PROF
STG
| Q4 25 | $4.5M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $4.5M | — | ||
| Q4 24 | — | $1.5M | ||
| Q2 24 | — | $1.8M | ||
| Q3 23 | — | $2.2M | ||
| Q2 23 | — | — |
股东权益
PROF
STG
| Q4 25 | $66.4M | — | ||
| Q3 25 | $32.1M | $17.7M | ||
| Q2 25 | $39.3M | $12.6M | ||
| Q1 25 | $50.8M | — | ||
| Q4 24 | — | $10.7M | ||
| Q2 24 | — | $7.6M | ||
| Q3 23 | — | $2.5M | ||
| Q2 23 | — | — |
总资产
PROF
STG
| Q4 25 | $77.5M | — | ||
| Q3 25 | $42.3M | $41.2M | ||
| Q2 25 | $49.7M | $40.3M | ||
| Q1 25 | $60.9M | — | ||
| Q4 24 | — | $42.4M | ||
| Q2 24 | — | $41.3M | ||
| Q3 23 | — | $40.0M | ||
| Q2 23 | — | — |
负债/权益比
PROF
STG
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | — | 0.14× | ||
| Q2 24 | — | 0.24× | ||
| Q3 23 | — | 0.86× | ||
| Q2 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-6.6M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
PROF
STG
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $-9.6M | — | ||
| Q2 25 | $-13.7M | — | ||
| Q1 25 | $-8.3M | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图